cancer of other female genital organs	is a	malignancy
cancer of other female genital organs	affects	uterus
cancer of other female genital organs	affects	cervix
cancer of other female genital organs	affects	vagina
cancer of other female genital organs	affects	vulva
cancer of other female genital organs	is a	gynecologic cancer
cancer of other female genital organs	is diagnosed with	imaging
cancer of other female genital organs	is diagnosed with	biopsy
cancer of other female genital organs	is staged by	FIGO
cancer of other female genital organs	is staged by	TNM
cancer of other female genital organs	is treated with	surgery
cancer of other female genital organs	is treated with	chemotherapy
cancer of other female genital organs	is treated with	radiotherapy
cancer of other female genital organs	is treated with	hormone therapy
cancer of other female genital organs	is treated with	targeted therapy
cancer of other female genital organs	is treated with	immunotherapy
cancer of other female genital organs	is treated with	palliative care
surgery	reduces	tumor burden
chemotherapy	reduces	metastasis risk
radiotherapy	reduces	local recurrence
hormone therapy	reduces	estrogen receptor activity
targeted therapy	inhibits	HER2
immunotherapy	activates	T‑cells
palliative care	improves	quality of life
cancer of other female genital organs	has risk factor	HPV infection
cancer of other female genital organs	has risk factor	smoking
cancer of other female genital organs	has risk factor	immunosuppression
cancer of other female genital organs	has risk factor	early menarche
cancer of other female genital organs	has risk factor	nulliparity
cancer of other female genital organs	has risk factor	obesity
cancer of other female genital organs	has symptom	abnormal bleeding
cancer of other female genital organs	has symptom	pelvic pain
cancer of other female genital organs	has symptom	urinary frequency
cancer of other female genital organs	has symptom	weight loss
cancer of other female genital organs	has symptom	fatigue
cancer of other female genital organs	leads to	anemia
cancer of other female genital organs	leads to	lymphadenopathy
cancer of other female genital organs	leads to	ascites
cancer of other female genital organs	leads to	metastasis
metastasis	occurs in	liver
metastasis	occurs in	lungs
metastasis	occurs in	bone
metastasis	occurs in	brain
cancer of other female genital organs	prognosis depends on	stage
cancer of other female genital organs	prognosis depends on	grade
cancer of other female genital organs	prognosis depends on	histology
cancer of other female genital organs	prognosis depends on	HPV status
cancer of other female genital organs	prognosis depends on	performance status
cancer of other female genital organs	prognosis depends on	comorbidities
cancer of other female genital organs	mortality risk increases with	advanced stage
cancer of other female genital organs	mortality risk increases with	poor response to therapy
cancer of other female genital organs	mortality risk increases with	age
cancer of other female genital organs	readmission risk increases with	postoperative complications
cancer of other female genital organs	readmission risk increases with	infection
cancer of other female genital organs	readmission risk increases with	anemia
cancer of other female genital organs	readmission risk increases with	pain
cancer of other female genital organs	readmission risk increases with	immobility
cancer of other female genital organs	readmission risk increases with	nutritional deficiency
cancer of other female genital organs	readmission risk increases with	chemotherapy toxicity
cancer of other female genital organs	readmission risk increases with	radiotherapy side effects
cancer of other female genital organs	readmission risk increases with	hormone therapy side effects
cancer of other female genital organs	readmission risk increases with	targeted therapy side effects
cancer of other female genital organs	readmission risk increases with	immunotherapy side effects
cancer of other female genital organs	readmission risk increases with	comorbid heart disease
cancer of other female genital organs	readmission risk increases with	comorbid kidney disease
cancer of other female genital organs	readmission risk increases with	comorbid diabetes
cancer of other female genital organs	readmission risk increases with	comorbid COPD
cancer of other female genital organs	readmission risk increases with	frailty
cancer of other female genital organs	readmission risk increases with	social isolation
cancer of other female genital organs	readmission risk increases with	lack of follow‑up
cancer of other female genital organs	readmission risk increases with	medication non‑adherence
cancer of other female genital organs	readmission risk increases with	pain management failure
cancer of other female genital organs	readmission risk increases with	infection risk
cancer of other female genital organs	readmission risk increases with	dehydration
cancer of other female genital organs	readmission risk increases with	electrolyte imbalance
cancer of other female genital organs	readmission risk increases with	anemia
cancer of other female genital organs	readmission risk increases with	thrombosis
cancer of other female genital organs	readmission risk increases with	bleeding
cancer of other female genital organs	readmission risk increases with	surgical site infection
cancer of other female genital organs	readmission risk increases with	urinary tract infection
cancer of other female genital organs	readmission risk increases with	pneumonia
cancer of other female genital organs	readmission risk increases with	sepsis
cancer of other female genital organs	readmission risk increases with	delirium
cancer of other female genital organs	readmission risk increases with	falls
cancer of other female genital organs	readmission risk increases with	pressure ulcers
cancer of other female genital organs	readmission risk increases with	malnutrition
cancer of other female genital organs	readmission risk increases with	depression
cancer of other female genital organs	readmission risk increases with	anxiety
cancer of other female genital organs	readmission risk increases with	caregiver burden
cancer of other female genital organs	readmission risk increases with	transportation barriers
cancer of other female genital organs	readmission risk increases with	medication cost
cancer of other female genital organs	readmission risk increases with	insurance coverage
cancer of other female genital organs	readmission risk increases with	health literacy
cancer of other female genital organs	readmission risk increases with	language barrier
cancer of other female genital organs	readmission risk increases with	cultural beliefs
cancer of other female genital organs	readmission risk increases with	lack of social support
cancer of other female genital organs	readmission risk increases with	postoperative pain
cancer of other female genital organs	readmission risk increases with	postoperative nausea
cancer of other female genital organs	readmission risk increases with	postoperative vomiting
cancer of other female genital organs	readmission risk increases with	postoperative fatigue
